Abstract | BACKGROUND: Hydroxyethylstarch used for volume restoration in brain-dead kidney donors has been associated with impaired kidney function in the transplant recipients. We undertook a multicentre randomised study to assess the frequency of acute renal failure (ARF) in patients with severe sepsis or septic shock treated with hydroxyethylstarch or gelatin. METHODS: FINDINGS: 129 patients were enrolled over 18 months. Severity of illness and serum creatinine (median 143 [IQR 88-203] vs 114 [91-175] micromol/L) were similar at baseline in the hydroxyethylstarch and gelatin groups. The frequencies of ARF (27/65 [42%] vs 15/64 [23%], p=0.028) and oliguria (35/62 [56%] vs 23/63 [37%], p=0.025) and the peak serum creatinine concentration (225 [130-339] vs 169 [106-273] micromol/L, p=0.04) were significantly higher in the hydroxyethylstarch group than in the gelatin group. In a multivariate analysis, risk factors for acute renal failure included mechanical ventilation (odds ratio 4.02 [95% CI 1.37-11.8], p=0.013) and use of hydroxyethylstarch (2.57 [1.13-5.83], p=0.026). INTERPRETATIONS: The use of this preparation of hydroxyethylstarch as a plasma-volume expander is an independent risk factor for ARF in patients with severe sepsis or septic shock.
|
Authors | F Schortgen, J C Lacherade, F Bruneel, I Cattaneo, F Hemery, F Lemaire, L Brochard |
Journal | Lancet (London, England)
(Lancet)
Vol. 357
Issue 9260
Pg. 911-6
(Mar 24 2001)
ISSN: 0140-6736 [Print] England |
PMID | 11289347
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hydroxyethyl Starch Derivatives
- Plasma Substitutes
- Gelatin
|
Topics |
- Acute Kidney Injury
(chemically induced)
- Adult
- Aged
- Female
- Fluid Therapy
(adverse effects, methods)
- France
(epidemiology)
- Gelatin
(adverse effects)
- Humans
- Hydroxyethyl Starch Derivatives
(adverse effects)
- Intensive Care Units
- Male
- Middle Aged
- Multivariate Analysis
- Plasma Substitutes
(adverse effects)
- Prospective Studies
- Risk
- Sepsis
(complications, mortality, therapy)
- Shock, Septic
(complications, mortality, therapy)
- Statistics, Nonparametric
- Survival Analysis
|